Skip to main content
Signal8

Walsh Kathleen E

SEC insider (Form 3/4/5 filer). CIK 0001667866. Director at Beam Therapeutics Inc. (BEAM). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in CAMBRIDGE, MA.

Companies Walsh Kathleen E has filed insider reports for

  • Beam Therapeutics Inc. (BEAM): Director
Walsh Kathleen E profile photo

Walsh Kathleen E

CIK: 0001667866

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Beam Therapeutics Inc. logo
BEAM

Beam Therapeutics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jun 3, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    19.7K shares-
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jun 4, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    33.7K shares-

1-2 of 2